메뉴 건너뛰기
Clinical Chemistry
Volumn 58, Issue 5, 2012, Pages 814-817
Lipoprotein-Associated phospholipase A2 measurements: Mass, activity, but little productivity
Author keywords

[No Author keywords available]
Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; APOLIPOPROTEIN; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DARAPLADIB; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPID; ROSUVASTATIN; SIMVASTATIN;
EID: 84860676336     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2012.183475     Document Type: Review
Times cited : (15)
References (16)
  • 6
    • 84871432301 scopus 로고    scopus 로고
    • US Food and Drug Administration 510(k) Summary: DiaDexus PLAC™ test(Accessed February 2012)
    • US Food and Drug Administration. 510(k) Summary: DiaDexus PLAC™ test. http://www.accessdata.fda.gov/cdrh-docs/pdf5/K050523.pdf (Accessed February 2012).
  • 7
    • 80053914425 scopus 로고    scopus 로고
    • Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
    • Davidson MH, Ballantyne CM, Jacobson TA, Bittner VA, Braun LT, Brown AS, et al. Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists. J Clin Lipidol 2011;5:338-67.
    • (2011) J Clin Lipidol , vol.5 , pp. 338-67
    • Davidson, M.H.1    Ballantyne, C.M.2    Jacobson, T.A.3    Bittner, V.A.4    Braun, L.T.5    Brown, A.S.6
  • 8
    • 0037126729 scopus 로고    scopus 로고
    • Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III) final report
    • National Cholesterol Education Program (NCEP)
    • National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
    • (2002) Circulation , vol.106 , pp. 3143-421
  • 9
    • 84860653236 scopus 로고    scopus 로고
    • 2 mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: An analysis from the JUPITER trial
    • 2 mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: An analysis from the JUPITER trial. Clin Chem 2012;58: 877-86.
    • (2012) Clin Chem , vol.58 , pp. 877-86
    • Ridker, P.M.1    MacFadyen, J.G.2    Wolfert, R.L.3    Koenig, W.4
  • 10
    • 77951605907 scopus 로고    scopus 로고
    • 2 and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies
    • 2 Studies Collaboration:
    • 2 and risk of coronary disease, stroke, and mortality: Collaborative analysis of 32 prospective studies. Lancet 2010;375:1536-44.
    • (2010) Lancet , vol.375 , pp. 1536-44
    • Thompson, A.1    Gao, P.2    Orfei, L.3    Watson, S.4    Di Angelantonio, E.5    Kaptoge, S.6
  • 11
    • 1342331006 scopus 로고    scopus 로고
    • 2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
    • DOI 10.1161/01.CIR.0000116763.91992.F1
    • 2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middleaged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004;109:837-42. (Pubitemid 38252734)
    • (2004) Circulation , vol.109 , Issue.7 , pp. 837-842
    • Ballantyne, C.M.1    Hoogeveen, R.C.2    Bang, H.3    Coresh, J.4    Folsom, A.R.5    Heiss, G.6    Sharrett, A.R.7
  • 12
    • 0346094369 scopus 로고    scopus 로고
    • Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia
    • DOI 10.1016/j.atherosclerosis.2003.09.019
    • Shimokata K, Yamada Y, Kondo T, Ichihara S, Izawa H, Nagata K, et al. Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 2004;172: 167-73. (Pubitemid 38058616)
    • (2004) Atherosclerosis , vol.172 , Issue.1 , pp. 167-173
    • Shimokata, K.1    Yamada, Y.2    Kondo, T.3    Ichihara, S.4    Izawa, H.5    Nagata, K.6    Murohara, T.7    Ohno, M.8    Yokota, M.9
  • 13
    • 77956306449 scopus 로고    scopus 로고
    • 2 activity and mass in relation to vascular disease and nonvascular mortality
    • Heart Protection Study Collaborative Group
    • 2 activity and mass in relation to vascular disease and nonvascular mortality. J Intern Med 2010;268:348-58.
    • (2010) J Intern Med , vol.268 , pp. 348-58
  • 14
    • 84871443922 scopus 로고    scopus 로고
    • ClinicalTrials.gov. The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial (STABILITY)(Accessed February )
    • ClinicalTrials.gov. The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial (STABILITY). http://clinicaltrials.gov/ ct2/show/NCT00799903 (Accessed February 2012).
    • (2012)
  • 15
    • 84871413565 scopus 로고    scopus 로고
    • GlaxoSmithKline. GSK initiates second pivotal Phase III trial for investigational cardiovascular medication darapladib( Accessed February )
    • GlaxoSmithKline. GSK initiates second pivotal Phase III trial for investigational cardiovascular medication darapladib. http://www.gsk.com/media/ pressreleases/2009/2009-pressrelease-10141.htm (Accessed February 2012).
    • (2012)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.